---
title: "Pre-market hot trades in US stocks: Zhongchao up 17.78% in pre-market; Global Engine up 14.23% in pre-market"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/271333905.md"
description: "Zhongchao rose 17.78% in pre-market; Global Engine rose 14.23% in pre-market; ChowChow Cloud rose 90.76% in pre-market; XTL Biopharmaceuticals rose 43.74% in pre-market; Eason Tech rose 41.83% in pre-market"
datetime: "2026-01-02T13:01:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/271333905.md)
  - [en](https://longbridge.com/en/news/271333905.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/271333905.md)
---

# Pre-market hot trades in US stocks: Zhongchao up 17.78% in pre-market; Global Engine up 14.23% in pre-market

**Popular Pre-Market Trades in US Stocks**

Zhongchao rose 17.78% in pre-market trading. There has been no significant news recently; trading is active, and capital flows are evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. no\_news

Global Engine rose 14.23% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

**Top Gainers in Pre-Market US Stocks**

ChowChow Cloud rose 90.76% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

XTL Biopharmaceuticals rose 43.74% in pre-market trading. Based on recent key news:

1.  On December 31, technical analysis indicated bearish sentiment. Despite the recent rise in stock price, the lack of details from the earnings call makes future performance uncertain. Technical signals suggest selling, with a market capitalization of $7.14 million. Source: EDGAR system
    
2.  On December 30, XTL Biopharmaceuticals released original content through the EDGAR system, emphasizing its financial assets, including shares of InterCure Ltd. Source: EDGAR system
    
3.  On December 29, XTL Biopharmaceuticals' activities include biopharmaceutical-related businesses and digital services revenue, which will be consolidated after the acquisition of The Social Proxy in August 2024. Source: EDGAR system. The biopharmaceutical industry has been highly volatile recently and requires attention.
    

Eason Tech rose 41.83% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation

### Related Stocks

- [ZCMD.US](https://longbridge.com/en/quote/ZCMD.US.md)
- [GLE.US](https://longbridge.com/en/quote/GLE.US.md)

## Related News & Research

- [ZAWYA: University of Sharjah’s My FarmWell application wins UAE Society of Engineers Excellence and Creative Engineering Award](https://longbridge.com/en/news/286879017.md)
- [Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors | IMUX Stock News](https://longbridge.com/en/news/286894992.md)
- [GE Aerospace Awarded U.S. Air Force Contract to Advance GE426 Engine for Autonomous Collaborative Platform | GE Stock News](https://longbridge.com/en/news/286943230.md)
- [ProShare Advisors LLC Buys 623,752 Shares of Gilead Sciences, Inc. $GILD](https://longbridge.com/en/news/286893590.md)
- [Maximilian Martin Discloses Investment at Enhanced Group Inc. with 8.3% Stake](https://longbridge.com/en/news/286473590.md)